English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Objective: This study investigated the effects of atorvastatin and artemisinin based combination therapies (ACTs), administered individually and orally co-administered on some hepatotoxic biomarkers and parasitemia counts in Plasmodium berghei NK65 strain infected mice. Methods: Twenty-five male Swiss albino mice were randomly distributed in five groups; Group I : ‘parasitized mice administered with atorvastatin’. Group II; ‘parasitized mice administered with atorvastatin + artesunate. Group III; ‘parasitized mice administered with atorvastatin + artemether. Group IV; ‘parasitized negative control group administered normal saline only’. Group V; ‘parasitized positive control group administered chloroquine’. Results: Plasma aspartate transaminase (AST), alanine transaminase (ALT), alkaline phosphate (ALP) and procalcitonin (PRO) activities were significantly reduced (p<0.05) in atorvastatin + artesunate, atorvastatin + artemether and chloroquine treated groups when compared with the negative control and atorvastatin treated group. Furthermore, the parasitemia count in Plasmodium berghei infected mice was suppressed in mice treated with atorvastatin + artesunate, atorvastatin + artemether and chloroquine when compared to mice treated with atorvastatin alone. Conclusion: The data from this study indicates that atorvastatin has a moderate potential in the clearance ability of Plasmodium berghei NK65 parasites and elicits hepatic and renal injury. It also indicates that the co-administration of artesunate and artemether with atorvastatin in the treatment of malaria could be beneficial with less severe hepatic and renal events.

trends in vector research and parasitology

Potency of atorvastatin in parasitemia clearance of plasmodium and the effects of the combination of atorvastatin and artemisinin derivatives on parasitemia clearance and organ toxicity